Myelodysplastic neoplasms

Introduction
Myelodysplastic neoplasms (World Health Organization [WHO] 2022) or myelodysplastic syndromes (International Consensus Classification [ICC] 2022), both abbreviated as MDS, are a heterogeneous group of clonal diseases of pluripotent hematopoietic stem cells that occur as a consequence of the progressive acquisition of somatic mutations. They have a higher incidence in males, especially from the age of 70. They are characterized by...

CITATION  Med Clin (Barc). 2023 Aug 19:S0025-7753(23)00467-0. doi: 10.1016/j.medcli.2023.07.017